Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Title Grant Type Focus Area Country Application Due Date Enzalutamide in the Treatment of Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network, AstellasResearch Oncology USA Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic DermatitisRelease Date:Education Inflammation & Immunology Japan Addressing Primary Immunodeficiencies within Minority/Underserved PopulationsRelease Date:Education Hospital USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant ProgramRelease Date:Quality Improvement Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.Release Date:Research Rare Disease USA Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)Release Date:Education Hospital All Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic DiseasesRelease Date:Partner: The Japan College of RheumatologyQuality Improvement Inflammation & Immunology Japan A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative DiseaseQuality Improvement Internal Medicine USA Establishment of Support System for Healthy Life Extension of Patients with CV diseaseRelease Date:Quality Improvement Internal Medicine Japan Racial and Ethnic Disparities in the Menopause ExperienceRelease Date:Education Internal Medicine USA Immunotherapy in Urothelial CarcinomaRelease Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology All Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASHRelease Date:Education Internal Medicine All